nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Sulfadiazine—malaria	0.107	0.167	CbGbCtD
Trametinib—CYP2C8—Pyrimethamine—malaria	0.107	0.167	CbGbCtD
Trametinib—CYP3A4—Clindamycin—malaria	0.0756	0.118	CbGbCtD
Trametinib—CYP2C8—Quinine—malaria	0.0551	0.0859	CbGbCtD
Trametinib—CYP2C8—Quinidine—malaria	0.0485	0.0755	CbGbCtD
Trametinib—CYP3A4—Sulfadiazine—malaria	0.0434	0.0676	CbGbCtD
Trametinib—CYP2C8—Dapsone—malaria	0.0418	0.0651	CbGbCtD
Trametinib—CYP3A4—Artemether—malaria	0.0369	0.0575	CbGbCtD
Trametinib—CYP3A4—Proguanil—malaria	0.0347	0.054	CbGbCtD
Trametinib—CYP3A4—Doxycycline—malaria	0.0329	0.0512	CbGbCtD
Trametinib—CYP3A4—Quinine—malaria	0.0224	0.0348	CbGbCtD
Trametinib—CYP3A4—Quinidine—malaria	0.0197	0.0306	CbGbCtD
Trametinib—CYP3A4—Dapsone—malaria	0.0169	0.0264	CbGbCtD
Trametinib—MAP2K2—blood plasma—malaria	0.00859	0.112	CbGeAlD
Trametinib—MAP2K1—hematopoietic system—malaria	0.0054	0.0706	CbGeAlD
Trametinib—MAP2K2—saliva-secreting gland—malaria	0.00498	0.0651	CbGeAlD
Trametinib—MAP2K2—hematopoietic system—malaria	0.00475	0.0621	CbGeAlD
Trametinib—MAP2K1—kidney—malaria	0.00442	0.0578	CbGeAlD
Trametinib—MAP2K2—kidney—malaria	0.00389	0.0509	CbGeAlD
Trametinib—MAP2K1—digestive system—malaria	0.00375	0.0491	CbGeAlD
Trametinib—MAP2K1—blood—malaria	0.00357	0.0468	CbGeAlD
Trametinib—MAP2K1—bone marrow—malaria	0.00346	0.0452	CbGeAlD
Trametinib—MAP2K2—digestive system—malaria	0.0033	0.0432	CbGeAlD
Trametinib—MAP2K2—blood—malaria	0.00315	0.0412	CbGeAlD
Trametinib—MAP2K2—bone marrow—malaria	0.00305	0.0398	CbGeAlD
Trametinib—CYP2C8—blood plasma—malaria	0.00297	0.0389	CbGeAlD
Trametinib—MAP2K1—liver—malaria	0.0028	0.0366	CbGeAlD
Trametinib—MAP2K2—liver—malaria	0.00246	0.0322	CbGeAlD
Trametinib—MAP2K1—brain—malaria	0.00222	0.029	CbGeAlD
Trametinib—CYP3A4—blood plasma—malaria	0.00202	0.0264	CbGeAlD
Trametinib—MAP2K2—brain—malaria	0.00195	0.0255	CbGeAlD
Trametinib—CYP2C8—hematopoietic system—malaria	0.00164	0.0215	CbGeAlD
Trametinib—CYP2C8—kidney—malaria	0.00135	0.0176	CbGeAlD
Trametinib—Bone disorder—Quinidine—malaria	0.00134	0.00912	CcSEcCtD
Trametinib—Bone disorder—Quinine—malaria	0.00134	0.00912	CcSEcCtD
Trametinib—Leukopenia—Pyrimethamine—malaria	0.00125	0.00853	CcSEcCtD
Trametinib—Bone disorder—Quinidine barbiturate—malaria	0.00121	0.00823	CcSEcCtD
Trametinib—Oropharyngeal pain—Pentoxifylline—malaria	0.0012	0.00816	CcSEcCtD
Trametinib—Hypocalcaemia—Quinidine barbiturate—malaria	0.00119	0.00812	CcSEcCtD
Trametinib—Mediastinal disorder—Proguanil—malaria	0.00113	0.00769	CcSEcCtD
Trametinib—Rash maculo-papular—Clindamycin—malaria	0.00112	0.00763	CcSEcCtD
Trametinib—Thrombocytopenia—Pyrimethamine—malaria	0.00112	0.00762	CcSEcCtD
Trametinib—CYP3A4—hematopoietic system—malaria	0.00111	0.0146	CbGeAlD
Trametinib—Mental disorder—Proguanil—malaria	0.0011	0.00747	CcSEcCtD
Trametinib—CYP2C8—blood—malaria	0.00109	0.0143	CbGeAlD
Trametinib—Erythema—Proguanil—malaria	0.00109	0.00742	CcSEcCtD
Trametinib—Malnutrition—Proguanil—malaria	0.00109	0.00742	CcSEcCtD
Trametinib—Pancreatitis—Sulfadiazine—malaria	0.00102	0.00693	CcSEcCtD
Trametinib—Decreased appetite—Pyrimethamine—malaria	0.000992	0.00676	CcSEcCtD
Trametinib—Cough—Proguanil—malaria	0.00095	0.00648	CcSEcCtD
Trametinib—Renal failure acute—Quinine—malaria	0.00095	0.00648	CcSEcCtD
Trametinib—Renal failure acute—Quinidine—malaria	0.00095	0.00648	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000921	0.00628	CcSEcCtD
Trametinib—CYP3A4—kidney—malaria	0.000913	0.0119	CbGeAlD
Trametinib—Stomatitis—Sulfadiazine—malaria	0.000902	0.00615	CcSEcCtD
Trametinib—Nervous system disorder—Proguanil—malaria	0.000872	0.00594	CcSEcCtD
Trametinib—Skin disorder—Proguanil—malaria	0.000863	0.00589	CcSEcCtD
Trametinib—Renal failure acute—Quinidine barbiturate—malaria	0.000857	0.00584	CcSEcCtD
Trametinib—CYP2C8—liver—malaria	0.000852	0.0111	CbGeAlD
Trametinib—Dry skin—Clindamycin—malaria	0.000819	0.00559	CcSEcCtD
Trametinib—Abdominal pain upper—Clindamycin—malaria	0.000817	0.00557	CcSEcCtD
Trametinib—Abdominal pain upper—Quinine—malaria	0.000801	0.00546	CcSEcCtD
Trametinib—Abdominal pain upper—Quinidine—malaria	0.000801	0.00546	CcSEcCtD
Trametinib—Pancreatitis—Dapsone—malaria	0.000783	0.00534	CcSEcCtD
Trametinib—CYP3A4—digestive system—malaria	0.000775	0.0101	CbGeAlD
Trametinib—Decreased appetite—Proguanil—malaria	0.000773	0.00527	CcSEcCtD
Trametinib—Gastrointestinal disorder—Proguanil—malaria	0.000767	0.00523	CcSEcCtD
Trametinib—Chills—Sulfadiazine—malaria	0.000745	0.00508	CcSEcCtD
Trametinib—Abdominal discomfort—Clindamycin—malaria	0.000741	0.00505	CcSEcCtD
Trametinib—CYP3A4—blood—malaria	0.000738	0.00965	CbGeAlD
Trametinib—Gastrointestinal pain—Proguanil—malaria	0.000727	0.00495	CcSEcCtD
Trametinib—Vomiting—Pyrimethamine—malaria	0.000725	0.00495	CcSEcCtD
Trametinib—Abdominal pain upper—Quinidine barbiturate—malaria	0.000723	0.00493	CcSEcCtD
Trametinib—Neutropenia—Clindamycin—malaria	0.000723	0.00493	CcSEcCtD
Trametinib—Neutropenia—Quinidine—malaria	0.000709	0.00483	CcSEcCtD
Trametinib—Neutropenia—Quinine—malaria	0.000709	0.00483	CcSEcCtD
Trametinib—Abdominal pain—Proguanil—malaria	0.000703	0.00479	CcSEcCtD
Trametinib—Body temperature increased—Proguanil—malaria	0.000703	0.00479	CcSEcCtD
Trametinib—CYP2C8—brain—malaria	0.000676	0.00884	CbGeAlD
Trametinib—Urinary tract infection—Clindamycin—malaria	0.00067	0.00456	CcSEcCtD
Trametinib—Renal failure—Quinidine—malaria	0.000664	0.00453	CcSEcCtD
Trametinib—Renal failure—Quinine—malaria	0.000664	0.00453	CcSEcCtD
Trametinib—Abdominal discomfort—Pentoxifylline—malaria	0.000655	0.00446	CcSEcCtD
Trametinib—Epistaxis—Clindamycin—malaria	0.00065	0.00443	CcSEcCtD
Trametinib—Leukopenia—Sulfadiazine—malaria	0.000647	0.00441	CcSEcCtD
Trametinib—Neutropenia—Quinidine barbiturate—malaria	0.00064	0.00436	CcSEcCtD
Trametinib—Bradycardia—Quinidine—malaria	0.000618	0.00421	CcSEcCtD
Trametinib—Bradycardia—Quinine—malaria	0.000618	0.00421	CcSEcCtD
Trametinib—Arthralgia—Sulfadiazine—malaria	0.000616	0.0042	CcSEcCtD
Trametinib—Haemoglobin—Quinidine—malaria	0.00061	0.00416	CcSEcCtD
Trametinib—Haemoglobin—Quinine—malaria	0.00061	0.00416	CcSEcCtD
Trametinib—Infestation NOS—Pentoxifylline—malaria	0.000609	0.00415	CcSEcCtD
Trametinib—Infestation—Pentoxifylline—malaria	0.000609	0.00415	CcSEcCtD
Trametinib—Diarrhoea—Proguanil—malaria	0.000608	0.00415	CcSEcCtD
Trametinib—Haemorrhage—Quinine—malaria	0.000607	0.00414	CcSEcCtD
Trametinib—Haemorrhage—Quinidine—malaria	0.000607	0.00414	CcSEcCtD
Trametinib—Renal failure—Quinidine barbiturate—malaria	0.0006	0.00409	CcSEcCtD
Trametinib—Urinary tract disorder—Quinidine—malaria	0.000599	0.00408	CcSEcCtD
Trametinib—Urinary tract disorder—Quinine—malaria	0.000599	0.00408	CcSEcCtD
Trametinib—Urethral disorder—Quinine—malaria	0.000595	0.00405	CcSEcCtD
Trametinib—Urethral disorder—Quinidine—malaria	0.000595	0.00405	CcSEcCtD
Trametinib—Thrombocytopenia—Sulfadiazine—malaria	0.000578	0.00394	CcSEcCtD
Trametinib—CYP3A4—liver—malaria	0.000577	0.00755	CbGeAlD
Trametinib—Epistaxis—Pentoxifylline—malaria	0.000574	0.00391	CcSEcCtD
Trametinib—Eye disorder—Quinidine—malaria	0.000567	0.00387	CcSEcCtD
Trametinib—Eye disorder—Quinine—malaria	0.000567	0.00387	CcSEcCtD
Trametinib—Vomiting—Proguanil—malaria	0.000565	0.00385	CcSEcCtD
Trametinib—Cardiac disorder—Quinidine—malaria	0.000563	0.00384	CcSEcCtD
Trametinib—Cardiac disorder—Quinine—malaria	0.000563	0.00384	CcSEcCtD
Trametinib—Rash—Proguanil—malaria	0.00056	0.00382	CcSEcCtD
Trametinib—Dermatitis—Proguanil—malaria	0.00056	0.00382	CcSEcCtD
Trametinib—Bradycardia—Quinidine barbiturate—malaria	0.000557	0.0038	CcSEcCtD
Trametinib—Headache—Proguanil—malaria	0.000557	0.0038	CcSEcCtD
Trametinib—Erythema—Dapsone—malaria	0.000557	0.00379	CcSEcCtD
Trametinib—Haemoglobin—Quinidine barbiturate—malaria	0.00055	0.00375	CcSEcCtD
Trametinib—Haemoglobin—Pentoxifylline—malaria	0.000549	0.00374	CcSEcCtD
Trametinib—Haemorrhage—Quinidine barbiturate—malaria	0.000548	0.00373	CcSEcCtD
Trametinib—Mediastinal disorder—Quinine—malaria	0.000547	0.00373	CcSEcCtD
Trametinib—Mediastinal disorder—Quinidine—malaria	0.000547	0.00373	CcSEcCtD
Trametinib—Haemorrhage—Pentoxifylline—malaria	0.000547	0.00373	CcSEcCtD
Trametinib—Chills—Quinidine—malaria	0.000544	0.00371	CcSEcCtD
Trametinib—Chills—Quinine—malaria	0.000544	0.00371	CcSEcCtD
Trametinib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000541	0.00369	CcSEcCtD
Trametinib—Erythema—Clindamycin—malaria	0.000538	0.00367	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000538	0.00366	CcSEcCtD
Trametinib—Urethral disorder—Quinidine barbiturate—malaria	0.000537	0.00366	CcSEcCtD
Trametinib—Insomnia—Sulfadiazine—malaria	0.000534	0.00364	CcSEcCtD
Trametinib—Mental disorder—Quinidine—malaria	0.000532	0.00362	CcSEcCtD
Trametinib—Mental disorder—Quinine—malaria	0.000532	0.00362	CcSEcCtD
Trametinib—Erythema—Quinidine—malaria	0.000528	0.0036	CcSEcCtD
Trametinib—Erythema—Quinine—malaria	0.000528	0.0036	CcSEcCtD
Trametinib—Malnutrition—Quinidine—malaria	0.000528	0.0036	CcSEcCtD
Trametinib—Malnutrition—Quinine—malaria	0.000528	0.0036	CcSEcCtD
Trametinib—Nausea—Proguanil—malaria	0.000528	0.0036	CcSEcCtD
Trametinib—Dysgeusia—Clindamycin—malaria	0.000527	0.00359	CcSEcCtD
Trametinib—Vision blurred—Dapsone—malaria	0.000525	0.00358	CcSEcCtD
Trametinib—Back pain—Clindamycin—malaria	0.000521	0.00355	CcSEcCtD
Trametinib—Muscle spasms—Clindamycin—malaria	0.000518	0.00353	CcSEcCtD
Trametinib—Decreased appetite—Sulfadiazine—malaria	0.000513	0.0035	CcSEcCtD
Trametinib—Eye disorder—Quinidine barbiturate—malaria	0.000512	0.00349	CcSEcCtD
Trametinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000509	0.00347	CcSEcCtD
Trametinib—Cardiac disorder—Quinidine barbiturate—malaria	0.000508	0.00346	CcSEcCtD
Trametinib—Vision blurred—Quinidine—malaria	0.000498	0.00339	CcSEcCtD
Trametinib—Vision blurred—Quinine—malaria	0.000498	0.00339	CcSEcCtD
Trametinib—Anaemia—Clindamycin—malaria	0.000498	0.00339	CcSEcCtD
Trametinib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000493	0.00336	CcSEcCtD
Trametinib—Chills—Quinidine barbiturate—malaria	0.000491	0.00335	CcSEcCtD
Trametinib—Arrhythmia—Pentoxifylline—malaria	0.000488	0.00333	CcSEcCtD
Trametinib—Cough—Dapsone—malaria	0.000486	0.00331	CcSEcCtD
Trametinib—Gastrointestinal pain—Sulfadiazine—malaria	0.000483	0.00329	CcSEcCtD
Trametinib—Leukopenia—Clindamycin—malaria	0.000482	0.00329	CcSEcCtD
Trametinib—Mental disorder—Quinidine barbiturate—malaria	0.00048	0.00327	CcSEcCtD
Trametinib—Malnutrition—Quinidine barbiturate—malaria	0.000477	0.00325	CcSEcCtD
Trametinib—Erythema—Quinidine barbiturate—malaria	0.000477	0.00325	CcSEcCtD
Trametinib—Erythema—Pentoxifylline—malaria	0.000476	0.00324	CcSEcCtD
Trametinib—Leukopenia—Quinine—malaria	0.000473	0.00322	CcSEcCtD
Trametinib—Leukopenia—Quinidine—malaria	0.000473	0.00322	CcSEcCtD
Trametinib—Body temperature increased—Sulfadiazine—malaria	0.000466	0.00318	CcSEcCtD
Trametinib—Abdominal pain—Sulfadiazine—malaria	0.000466	0.00318	CcSEcCtD
Trametinib—Dysgeusia—Pentoxifylline—malaria	0.000466	0.00318	CcSEcCtD
Trametinib—Hypertension—Clindamycin—malaria	0.000465	0.00317	CcSEcCtD
Trametinib—Back pain—Pentoxifylline—malaria	0.00046	0.00314	CcSEcCtD
Trametinib—Muscle spasms—Pentoxifylline—malaria	0.000457	0.00312	CcSEcCtD
Trametinib—Myalgia—Quinine—malaria	0.00045	0.00307	CcSEcCtD
Trametinib—Myalgia—Quinidine—malaria	0.00045	0.00307	CcSEcCtD
Trametinib—Vision blurred—Quinidine barbiturate—malaria	0.000449	0.00306	CcSEcCtD
Trametinib—Vision blurred—Pentoxifylline—malaria	0.000448	0.00306	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000447	0.00304	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000447	0.00304	CcSEcCtD
Trametinib—Anaemia—Pentoxifylline—malaria	0.00044	0.003	CcSEcCtD
Trametinib—Oedema—Quinine—malaria	0.000431	0.00294	CcSEcCtD
Trametinib—Oedema—Quinidine—malaria	0.000431	0.00294	CcSEcCtD
Trametinib—Thrombocytopenia—Clindamycin—malaria	0.00043	0.00293	CcSEcCtD
Trametinib—Leukopenia—Quinidine barbiturate—malaria	0.000427	0.00291	CcSEcCtD
Trametinib—Leukopenia—Pentoxifylline—malaria	0.000426	0.0029	CcSEcCtD
Trametinib—Nervous system disorder—Quinidine—malaria	0.000423	0.00288	CcSEcCtD
Trametinib—Nervous system disorder—Quinine—malaria	0.000423	0.00288	CcSEcCtD
Trametinib—Thrombocytopenia—Quinine—malaria	0.000422	0.00288	CcSEcCtD
Trametinib—Thrombocytopenia—Quinidine—malaria	0.000422	0.00288	CcSEcCtD
Trametinib—Skin disorder—Quinidine—malaria	0.000419	0.00285	CcSEcCtD
Trametinib—Skin disorder—Quinine—malaria	0.000419	0.00285	CcSEcCtD
Trametinib—Pruritus—Sulfadiazine—malaria	0.000417	0.00285	CcSEcCtD
Trametinib—Hyperhidrosis—Quinidine—malaria	0.000417	0.00284	CcSEcCtD
Trametinib—Hyperhidrosis—Quinine—malaria	0.000417	0.00284	CcSEcCtD
Trametinib—Insomnia—Dapsone—malaria	0.000411	0.0028	CcSEcCtD
Trametinib—Hypertension—Pentoxifylline—malaria	0.000411	0.0028	CcSEcCtD
Trametinib—Arthralgia—Quinidine barbiturate—malaria	0.000406	0.00277	CcSEcCtD
Trametinib—Myalgia—Quinidine barbiturate—malaria	0.000406	0.00277	CcSEcCtD
Trametinib—Myalgia—Pentoxifylline—malaria	0.000405	0.00276	CcSEcCtD
Trametinib—Diarrhoea—Sulfadiazine—malaria	0.000404	0.00275	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000403	0.00275	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000402	0.00274	CcSEcCtD
Trametinib—Dry mouth—Pentoxifylline—malaria	0.000396	0.0027	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Quinidine—malaria	0.000393	0.00268	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Quinine—malaria	0.000393	0.00268	CcSEcCtD
Trametinib—Oedema—Quinidine barbiturate—malaria	0.000389	0.00265	CcSEcCtD
Trametinib—Oedema—Pentoxifylline—malaria	0.000388	0.00265	CcSEcCtD
Trametinib—Infection—Pentoxifylline—malaria	0.000386	0.00263	CcSEcCtD
Trametinib—Nervous system disorder—Quinidine barbiturate—malaria	0.000382	0.0026	CcSEcCtD
Trametinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000381	0.0026	CcSEcCtD
Trametinib—Thrombocytopenia—Pentoxifylline—malaria	0.00038	0.00259	CcSEcCtD
Trametinib—Gastrointestinal disorder—Clindamycin—malaria	0.000379	0.00259	CcSEcCtD
Trametinib—Fatigue—Clindamycin—malaria	0.000379	0.00258	CcSEcCtD
Trametinib—Skin disorder—Quinidine barbiturate—malaria	0.000378	0.00258	CcSEcCtD
Trametinib—Skin disorder—Pentoxifylline—malaria	0.000377	0.00257	CcSEcCtD
Trametinib—Hyperhidrosis—Quinidine barbiturate—malaria	0.000376	0.00256	CcSEcCtD
Trametinib—Constipation—Clindamycin—malaria	0.000376	0.00256	CcSEcCtD
Trametinib—Hyperhidrosis—Pentoxifylline—malaria	0.000375	0.00256	CcSEcCtD
Trametinib—Vomiting—Sulfadiazine—malaria	0.000375	0.00256	CcSEcCtD
Trametinib—Decreased appetite—Quinidine—malaria	0.000375	0.00255	CcSEcCtD
Trametinib—Decreased appetite—Quinine—malaria	0.000375	0.00255	CcSEcCtD
Trametinib—Gastrointestinal disorder—Quinidine—malaria	0.000372	0.00254	CcSEcCtD
Trametinib—Gastrointestinal disorder—Quinine—malaria	0.000372	0.00254	CcSEcCtD
Trametinib—Rash—Sulfadiazine—malaria	0.000372	0.00254	CcSEcCtD
Trametinib—Dermatitis—Sulfadiazine—malaria	0.000372	0.00253	CcSEcCtD
Trametinib—Gastrointestinal pain—Dapsone—malaria	0.000371	0.00253	CcSEcCtD
Trametinib—Headache—Sulfadiazine—malaria	0.00037	0.00252	CcSEcCtD
Trametinib—Gastrointestinal pain—Clindamycin—malaria	0.000359	0.00245	CcSEcCtD
Trametinib—Abdominal pain—Dapsone—malaria	0.000359	0.00245	CcSEcCtD
Trametinib—Body temperature increased—Dapsone—malaria	0.000359	0.00245	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000354	0.00242	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000354	0.00241	CcSEcCtD
Trametinib—Gastrointestinal pain—Quinidine—malaria	0.000352	0.0024	CcSEcCtD
Trametinib—Gastrointestinal pain—Quinine—malaria	0.000352	0.0024	CcSEcCtD
Trametinib—Insomnia—Pentoxifylline—malaria	0.000351	0.00239	CcSEcCtD
Trametinib—Nausea—Sulfadiazine—malaria	0.00035	0.00239	CcSEcCtD
Trametinib—Abdominal pain—Clindamycin—malaria	0.000347	0.00237	CcSEcCtD
Trametinib—Body temperature increased—Clindamycin—malaria	0.000347	0.00237	CcSEcCtD
Trametinib—Abdominal pain—Quinine—malaria	0.000341	0.00232	CcSEcCtD
Trametinib—Body temperature increased—Quinidine—malaria	0.000341	0.00232	CcSEcCtD
Trametinib—Body temperature increased—Quinine—malaria	0.000341	0.00232	CcSEcCtD
Trametinib—Abdominal pain—Quinidine—malaria	0.000341	0.00232	CcSEcCtD
Trametinib—Decreased appetite—Quinidine barbiturate—malaria	0.000338	0.00231	CcSEcCtD
Trametinib—Decreased appetite—Pentoxifylline—malaria	0.000338	0.0023	CcSEcCtD
Trametinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000336	0.00229	CcSEcCtD
Trametinib—Constipation—Quinidine barbiturate—malaria	0.000333	0.00227	CcSEcCtD
Trametinib—Constipation—Pentoxifylline—malaria	0.000332	0.00226	CcSEcCtD
Trametinib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000318	0.00217	CcSEcCtD
Trametinib—Gastrointestinal pain—Pentoxifylline—malaria	0.000318	0.00216	CcSEcCtD
Trametinib—Asthenia—Clindamycin—malaria	0.000315	0.00215	CcSEcCtD
Trametinib—Pruritus—Clindamycin—malaria	0.000311	0.00212	CcSEcCtD
Trametinib—Asthenia—Quinine—malaria	0.000309	0.00211	CcSEcCtD
Trametinib—Asthenia—Quinidine—malaria	0.000309	0.00211	CcSEcCtD
Trametinib—Abdominal pain—Quinidine barbiturate—malaria	0.000308	0.0021	CcSEcCtD
Trametinib—Body temperature increased—Quinidine barbiturate—malaria	0.000308	0.0021	CcSEcCtD
Trametinib—Abdominal pain—Pentoxifylline—malaria	0.000307	0.00209	CcSEcCtD
Trametinib—Body temperature increased—Pentoxifylline—malaria	0.000307	0.00209	CcSEcCtD
Trametinib—Pruritus—Quinidine—malaria	0.000305	0.00208	CcSEcCtD
Trametinib—Pruritus—Quinine—malaria	0.000305	0.00208	CcSEcCtD
Trametinib—Diarrhoea—Clindamycin—malaria	0.000301	0.00205	CcSEcCtD
Trametinib—Diarrhoea—Quinidine—malaria	0.000295	0.00201	CcSEcCtD
Trametinib—Diarrhoea—Quinine—malaria	0.000295	0.00201	CcSEcCtD
Trametinib—Dizziness—Clindamycin—malaria	0.000291	0.00198	CcSEcCtD
Trametinib—Vomiting—Dapsone—malaria	0.000289	0.00197	CcSEcCtD
Trametinib—Dizziness—Quinidine—malaria	0.000285	0.00194	CcSEcCtD
Trametinib—Dizziness—Quinine—malaria	0.000285	0.00194	CcSEcCtD
Trametinib—Headache—Dapsone—malaria	0.000285	0.00194	CcSEcCtD
Trametinib—Vomiting—Clindamycin—malaria	0.000279	0.0019	CcSEcCtD
Trametinib—Asthenia—Quinidine barbiturate—malaria	0.000279	0.0019	CcSEcCtD
Trametinib—Asthenia—Pentoxifylline—malaria	0.000279	0.0019	CcSEcCtD
Trametinib—Rash—Clindamycin—malaria	0.000277	0.00189	CcSEcCtD
Trametinib—Dermatitis—Clindamycin—malaria	0.000277	0.00189	CcSEcCtD
Trametinib—Headache—Clindamycin—malaria	0.000275	0.00188	CcSEcCtD
Trametinib—Pruritus—Quinidine barbiturate—malaria	0.000275	0.00188	CcSEcCtD
Trametinib—Pruritus—Pentoxifylline—malaria	0.000275	0.00187	CcSEcCtD
Trametinib—Vomiting—Quinidine—malaria	0.000274	0.00187	CcSEcCtD
Trametinib—Vomiting—Quinine—malaria	0.000274	0.00187	CcSEcCtD
Trametinib—Rash—Quinidine—malaria	0.000272	0.00185	CcSEcCtD
Trametinib—Rash—Quinine—malaria	0.000272	0.00185	CcSEcCtD
Trametinib—Dermatitis—Quinidine—malaria	0.000272	0.00185	CcSEcCtD
Trametinib—Dermatitis—Quinine—malaria	0.000272	0.00185	CcSEcCtD
Trametinib—Headache—Quinidine—malaria	0.00027	0.00184	CcSEcCtD
Trametinib—Headache—Quinine—malaria	0.00027	0.00184	CcSEcCtD
Trametinib—Nausea—Dapsone—malaria	0.00027	0.00184	CcSEcCtD
Trametinib—Diarrhoea—Quinidine barbiturate—malaria	0.000266	0.00181	CcSEcCtD
Trametinib—Diarrhoea—Pentoxifylline—malaria	0.000266	0.00181	CcSEcCtD
Trametinib—Nausea—Clindamycin—malaria	0.000261	0.00178	CcSEcCtD
Trametinib—Dizziness—Quinidine barbiturate—malaria	0.000257	0.00175	CcSEcCtD
Trametinib—Dizziness—Pentoxifylline—malaria	0.000257	0.00175	CcSEcCtD
Trametinib—Nausea—Quinine—malaria	0.000256	0.00175	CcSEcCtD
Trametinib—Nausea—Quinidine—malaria	0.000256	0.00175	CcSEcCtD
Trametinib—Vomiting—Quinidine barbiturate—malaria	0.000247	0.00169	CcSEcCtD
Trametinib—Vomiting—Pentoxifylline—malaria	0.000247	0.00168	CcSEcCtD
Trametinib—Rash—Quinidine barbiturate—malaria	0.000245	0.00167	CcSEcCtD
Trametinib—Dermatitis—Quinidine barbiturate—malaria	0.000245	0.00167	CcSEcCtD
Trametinib—Rash—Pentoxifylline—malaria	0.000245	0.00167	CcSEcCtD
Trametinib—Dermatitis—Pentoxifylline—malaria	0.000245	0.00167	CcSEcCtD
Trametinib—Headache—Quinidine barbiturate—malaria	0.000244	0.00166	CcSEcCtD
Trametinib—Headache—Pentoxifylline—malaria	0.000243	0.00166	CcSEcCtD
Trametinib—Nausea—Quinidine barbiturate—malaria	0.000231	0.00158	CcSEcCtD
Trametinib—Nausea—Pentoxifylline—malaria	0.000231	0.00157	CcSEcCtD
Trametinib—MAP2K1—FRS2-mediated cascade—IL6—malaria	0.000197	0.00146	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—FAS—malaria	0.000197	0.00146	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CR1—malaria	0.000195	0.00144	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—IL1B—malaria	0.000189	0.00141	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—TNF—malaria	0.000188	0.0014	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—IFNG—malaria	0.000188	0.00139	CbGpPWpGaD
Trametinib—MAP2K1—Interleukin-2 signaling—IL6—malaria	0.000187	0.00139	CbGpPWpGaD
Trametinib—MAP2K1—TSLP Signaling Pathway—IL6—malaria	0.000187	0.00139	CbGpPWpGaD
Trametinib—MAP2K1—Corticotropin-releasing hormone—IL2—malaria	0.000185	0.00138	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—IL1B—malaria	0.000183	0.00136	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000177	0.00132	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TLR9—malaria	0.000177	0.00131	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—TNF—malaria	0.000176	0.00131	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—HPGDS—malaria	0.000175	0.0013	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL1B—malaria	0.000175	0.0013	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL2—malaria	0.000174	0.00129	CbGpPWpGaD
Trametinib—MAP2K2—MAP kinase activation in TLR cascade—IL6—malaria	0.000173	0.00129	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—IL1B—malaria	0.000171	0.00127	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—KDR—malaria	0.000171	0.00127	CbGpPWpGaD
Trametinib—MAP2K2—SHP2 signaling—IL6—malaria	0.000169	0.00125	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—IL1B—malaria	0.000167	0.00124	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TLR9—malaria	0.000165	0.00123	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL1B—malaria	0.000164	0.00122	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL2—malaria	0.000163	0.00121	CbGpPWpGaD
Trametinib—MAP2K1—MAP kinase activation in TLR cascade—IL6—malaria	0.000162	0.0012	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—KDR—malaria	0.00016	0.00119	CbGpPWpGaD
Trametinib—MAP2K1—SHP2 signaling—IL6—malaria	0.000158	0.00117	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL18—malaria	0.000156	0.00116	CbGpPWpGaD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.000155	0.00115	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CISH—malaria	0.000155	0.00115	CbGpPWpGaD
Trametinib—MAP2K2—NCAM signaling for neurite out-growth—IL6—malaria	0.000148	0.0011	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HLA-B—malaria	0.000148	0.0011	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL18—malaria	0.000146	0.00109	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FCGR2B—malaria	0.000146	0.00109	CbGpPWpGaD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	0.000145	0.00108	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CISH—malaria	0.000145	0.00108	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IL1B—malaria	0.000143	0.00106	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FCGR2A—malaria	0.000141	0.00105	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—ACKR1—malaria	0.00014	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—NCAM signaling for neurite out-growth—IL6—malaria	0.000139	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HLA-B—malaria	0.000139	0.00103	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	0.000137	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FCGR2B—malaria	0.000137	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL1B—malaria	0.000134	0.000994	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—TNF—malaria	0.000133	0.000987	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FCGR2A—malaria	0.000132	0.000982	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—ACKR1—malaria	0.000131	0.000971	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TIRAP—malaria	0.00013	0.000967	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	0.000128	0.000953	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—TNF—malaria	0.000124	0.000924	CbGpPWpGaD
Trametinib—MAP2K2—IRS-mediated signalling—IL6—malaria	0.000124	0.000922	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 cascade initiated on plasma membrane—IL6—malaria	0.000124	0.000922	CbGpPWpGaD
Trametinib—MAP2K2—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	0.000123	0.000913	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—IL1B—malaria	0.000123	0.000913	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000123	0.000912	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TIRAP—malaria	0.000122	0.000905	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CR1—malaria	0.000121	0.000899	CbGpPWpGaD
Trametinib—MAP2K2—MyD88 dependent cascade initiated on endosome—IL6—malaria	0.000121	0.000896	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events—IL6—malaria	0.000121	0.000896	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—ICAM1—malaria	0.00012	0.000894	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events triggered by IGF1R—IL6—malaria	0.00012	0.000888	CbGpPWpGaD
Trametinib—MAP2K2—TCR Signaling Pathway—IL6—malaria	0.000119	0.00088	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	0.000117	0.000865	CbGpPWpGaD
Trametinib—MAP2K2—Insulin receptor signalling cascade—IL6—malaria	0.000117	0.000865	CbGpPWpGaD
Trametinib—MAP2K2—IGF1R signaling cascade—IL6—malaria	0.000117	0.000865	CbGpPWpGaD
Trametinib—MAP2K1—IRS-mediated signalling—IL6—malaria	0.000116	0.000862	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 cascade initiated on plasma membrane—IL6—malaria	0.000116	0.000862	CbGpPWpGaD
Trametinib—MAP2K1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	0.000115	0.000854	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—IL1B—malaria	0.000115	0.000854	CbGpPWpGaD
Trametinib—MAP2K2—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	0.000115	0.00085	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CR1—malaria	0.000113	0.000841	CbGpPWpGaD
Trametinib—MAP2K1—MyD88 dependent cascade initiated on endosome—IL6—malaria	0.000113	0.000839	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events—IL6—malaria	0.000113	0.000839	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—ICAM1—malaria	0.000113	0.000836	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events triggered by IGF1R—IL6—malaria	0.000112	0.000831	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PKLR—malaria	0.000112	0.00083	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—KDR—malaria	0.000112	0.000829	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—IL6—malaria	0.000111	0.000824	CbGpPWpGaD
Trametinib—MAP2K2—MyD88-independent cascade—IL6—malaria	0.00011	0.000816	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	0.000109	0.000809	CbGpPWpGaD
Trametinib—MAP2K1—IGF1R signaling cascade—IL6—malaria	0.000109	0.000809	CbGpPWpGaD
Trametinib—MAP2K1—Insulin receptor signalling cascade—IL6—malaria	0.000109	0.000809	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—IL6—malaria	0.000107	0.000797	CbGpPWpGaD
Trametinib—MAP2K1—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	0.000107	0.000796	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PKLR—malaria	0.000105	0.000777	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—KDR—malaria	0.000105	0.000776	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TNF—malaria	0.000104	0.000771	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—IL6—malaria	0.000103	0.000767	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR9—malaria	0.000103	0.000765	CbGpPWpGaD
Trametinib—MAP2K1—MyD88-independent cascade—IL6—malaria	0.000103	0.000763	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—IL6—malaria	0.000102	0.000761	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—IL6—malaria	0.0001	0.000745	CbGpPWpGaD
Trametinib—MAP2K2—Disease—G6PD—malaria	9.97e-05	0.00074	CbGpPWpGaD
Trametinib—MAP2K2—Activated TLR4 signalling—IL6—malaria	9.88e-05	0.000734	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—IL6—malaria	9.81e-05	0.000728	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—IL6—malaria	9.75e-05	0.000724	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—malaria	9.71e-05	0.000721	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—IL6—malaria	9.68e-05	0.000719	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—IL6—malaria	9.66e-05	0.000717	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR9—malaria	9.64e-05	0.000715	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—IL6—malaria	9.59e-05	0.000712	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—HPGDS—malaria	9.41e-05	0.000698	CbGpPWpGaD
Trametinib—MAP2K1—Disease—G6PD—malaria	9.33e-05	0.000692	CbGpPWpGaD
Trametinib—MAP2K2—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	9.3e-05	0.00069	CbGpPWpGaD
Trametinib—MAP2K1—Activated TLR4 signalling—IL6—malaria	9.25e-05	0.000687	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CD36—malaria	9.22e-05	0.000685	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IFNG—malaria	9.16e-05	0.00068	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—IL6—malaria	9.12e-05	0.000677	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—IL6—malaria	9.06e-05	0.000672	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—malaria	8.92e-05	0.000662	CbGpPWpGaD
Trametinib—MAP2K1—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	8.7e-05	0.000646	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CD36—malaria	8.63e-05	0.000641	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IFNG—malaria	8.57e-05	0.000636	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—IL6—malaria	8.38e-05	0.000622	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—malaria	8.34e-05	0.00062	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HLA-B—malaria	8.31e-05	0.000617	CbGpPWpGaD
Trametinib—MAP2K2—Toll-Like Receptors Cascades—IL6—malaria	8.28e-05	0.000615	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—IL6—malaria	8.28e-05	0.000615	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ACKR1—malaria	8.26e-05	0.000613	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FCGR2A—malaria	8.23e-05	0.000611	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL1B—malaria	8.17e-05	0.000606	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD36—malaria	8.14e-05	0.000605	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL2—malaria	8.14e-05	0.000604	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—KDR—malaria	7.97e-05	0.000592	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—IL6—malaria	7.92e-05	0.000588	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—IL6—malaria	7.84e-05	0.000582	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—IL6—malaria	7.8e-05	0.000579	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HLA-B—malaria	7.77e-05	0.000577	CbGpPWpGaD
Trametinib—MAP2K1—Toll-Like Receptors Cascades—IL6—malaria	7.75e-05	0.000575	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—IL6—malaria	7.75e-05	0.000575	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ACKR1—malaria	7.73e-05	0.000574	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FCGR2A—malaria	7.7e-05	0.000572	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL1B—malaria	7.64e-05	0.000567	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD36—malaria	7.62e-05	0.000566	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL2—malaria	7.61e-05	0.000565	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.53e-05	0.000559	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—KDR—malaria	7.46e-05	0.000554	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—IL6—malaria	7.45e-05	0.000553	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—IL6—malaria	7.41e-05	0.00055	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—IL6—malaria	7.41e-05	0.00055	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—IL6—malaria	7.37e-05	0.000547	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CRP—malaria	7.34e-05	0.000545	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—IL6—malaria	7.34e-05	0.000545	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—malaria	7.3e-05	0.000542	CbGpPWpGaD
Trametinib—MAP2K2—Disease—DHFR—malaria	7.05e-05	0.000524	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TLR4—malaria	7.04e-05	0.000523	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—IL6—malaria	6.97e-05	0.000517	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—malaria	6.93e-05	0.000515	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—malaria	6.9e-05	0.000513	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	6.9e-05	0.000513	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—malaria	6.9e-05	0.000513	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—malaria	6.9e-05	0.000512	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CRP—malaria	6.87e-05	0.00051	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—malaria	6.87e-05	0.00051	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DHODH—malaria	6.84e-05	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—malaria	6.84e-05	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—malaria	6.78e-05	0.000503	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—malaria	6.75e-05	0.000501	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.73e-05	0.0005	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TLR9—malaria	6.66e-05	0.000494	CbGpPWpGaD
Trametinib—MAP2K1—Disease—DHFR—malaria	6.6e-05	0.00049	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TLR4—malaria	6.59e-05	0.000489	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—malaria	6.46e-05	0.00048	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—malaria	6.46e-05	0.00048	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—malaria	6.46e-05	0.00048	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—malaria	6.4e-05	0.000475	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—malaria	6.34e-05	0.000471	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—malaria	6.32e-05	0.000469	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TLR9—malaria	6.23e-05	0.000463	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	6.18e-05	0.000459	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	6.11e-05	0.000454	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	5.91e-05	0.000439	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC4A1—malaria	5.82e-05	0.000432	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—malaria	5.72e-05	0.000425	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	5.53e-05	0.00041	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DECR1—malaria	5.47e-05	0.000406	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL18—malaria	5.11e-05	0.000379	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD40LG—malaria	5.09e-05	0.000378	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD8A—malaria	5.03e-05	0.000373	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—malaria	4.96e-05	0.000368	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HBB—malaria	4.95e-05	0.000367	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-B—malaria	4.84e-05	0.000359	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—malaria	4.78e-05	0.000355	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL18—malaria	4.78e-05	0.000355	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD40LG—malaria	4.76e-05	0.000353	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD36—malaria	4.74e-05	0.000352	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD8A—malaria	4.71e-05	0.000349	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—malaria	4.7e-05	0.000349	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—malaria	4.64e-05	0.000345	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-B—malaria	4.53e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—malaria	4.48e-05	0.000332	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD36—malaria	4.44e-05	0.00033	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PKLR—malaria	4.41e-05	0.000327	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—malaria	4.4e-05	0.000327	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—malaria	4.28e-05	0.000318	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—malaria	4.26e-05	0.000316	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR4—malaria	4.1e-05	0.000304	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—malaria	4e-05	0.000297	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—malaria	3.98e-05	0.000296	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—ICAM1—malaria	3.93e-05	0.000292	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—G6PD—malaria	3.93e-05	0.000292	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	3.88e-05	0.000288	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR4—malaria	3.84e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—malaria	3.76e-05	0.000279	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—ICAM1—malaria	3.68e-05	0.000273	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DHODH—malaria	3.67e-05	0.000273	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS2—malaria	3.6e-05	0.000267	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—malaria	3.52e-05	0.000261	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS2—malaria	3.37e-05	0.00025	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC4A1—malaria	3.12e-05	0.000232	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—malaria	3.04e-05	0.000225	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HPGDS—malaria	3e-05	0.000223	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—malaria	2.99e-05	0.000222	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DECR1—malaria	2.94e-05	0.000218	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—malaria	2.91e-05	0.000216	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—malaria	2.89e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—malaria	2.84e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—malaria	2.8e-05	0.000208	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—DHFR—malaria	2.78e-05	0.000206	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SCARB1—malaria	2.75e-05	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—malaria	2.72e-05	0.000202	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—malaria	2.7e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—malaria	2.68e-05	0.000199	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—malaria	2.67e-05	0.000198	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—malaria	2.67e-05	0.000198	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—malaria	2.66e-05	0.000197	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBB—malaria	2.66e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KDR—malaria	2.65e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—malaria	2.51e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—malaria	2.5e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—malaria	2.5e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—malaria	2.49e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KDR—malaria	2.48e-05	0.000184	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PKLR—malaria	2.37e-05	0.000176	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PD—malaria	2.11e-05	0.000157	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—malaria	1.73e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—malaria	1.72e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—malaria	1.71e-05	0.000127	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HPGDS—malaria	1.61e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—malaria	1.61e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—malaria	1.6e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—malaria	1.56e-05	0.000116	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DHFR—malaria	1.49e-05	0.000111	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SCARB1—malaria	1.48e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—malaria	1.46e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—malaria	1.44e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—malaria	1.35e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—malaria	1.01e-05	7.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—malaria	9.45e-06	7.02e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—malaria	9.27e-06	6.88e-05	CbGpPWpGaD
